BioCatalyst

GNLX — GENELUX Corp catalysts

1 verified catalyst event(s) for GENELUX Corp (ticker GNLX). Each is linked to its official source. Verified as of 2026-08-06.

Next verified catalyst

2026-12-01 — Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's C · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12 (month)
in 4mo
ESTIMATED
 READOUT
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Phy
Phase 3 · Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer
 GNLX GENELUX Corp olvimulogene nanivacirepvec, Platinum ch ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.